AEGiS-UPI: Annan turns to business on AIDS United Press InternationalImportant note: Information in this article was accurate in 2001. The state of the art may have changed since the publication date.
Click here to return to United Press International main menu
DonateNow
Print this article




Annan turns to business on AIDS

United Press International - Friday, 1 June 2001
Martin Walker, Chief International Correspondent


WASHINGTON, June 1 (UPI) -- American and world business leaders must realize that the HIV/AIDS epidemic is a direct threat to their markets and profits, and get involved in battle against the disease, U.N. Secretary-General Kofi Annan told the U.S. Chamber of Commerce Friday.

"As 42 percent of U.S. exports go to markets in the developing world, the negative impact of AIDS on American business should be obvious," Annan said. "The business community needs to get involved to protect its bottom line."

The bill for a global AIDS campaign in lower- and middle-income countries would be close to $10 billion -- five times more than government, citizens and international donors are currently spending.

"It may sound like a lot, but Harvard has estimated that AIDS has already cost the world more than $500 billion," Annan said. "So $10 billion a year to defeat seems reasonable -- indeed, a bargain."

"AIDS affects business," he said. "The spread of the pandemic has caused business costs to expand and markets to shrink."

He said AIDS disrupted economies because it killed people in the prime of their lives. He said it tended to strike urban centers, the better educated, the leadership elite and the most productive members of society.

Annan won two standing ovations from the chamber, which, as the world's largest business federation, represents 3 million companies, 3,000 state and local chambers, 800 business associations and 87 American Chambers of Commerce abroad.

They responded warmly to his pledge to respect intellectual property rights and patents, and to "work closely with the pharmaceutical industry -- companies need incentives to continue their research."

"I come to you, the leaders of American business, representatives of one of the greatest forces in the world, but one which has yet to be fully utilized in the campaign against HIV/AIDS," Annan said. "It is time we tapped your strength to the full."

He cited examples from around the world of businesses that had made a difference.

In Brazil, Volkswagen had launched an HIV prevention and education campaign in the workplace. Within three years, the company saw a 90 percent drop in hospitalization rates among HIV-positive workers and a 40 percent drop in the cost of treatment and care.

"This led to increased productivity, reduced absenteeism, reduced the loss of employees to AIDS and higher morale in the workforce," Annan said. "Ad a result, many families kept their breadwinners and many children still have their parents."

In Thailand, some insurance companies have started giving preferential rates to companies that developed HIV programs in the workplace, and have seen direct benefits through lower medical costs and gaining new business.
010601
UP010602


Copyright © 2001 - United Press International. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through United Press International, Permissions Desk, 1510 H St. N.W. Washington DC 2005. Main Phone Switchboard: 202-898-8000 FAX: 202-898-8057 or 202-898-8147 Email: info@upi.com.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation UK, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .